Longitudinal ctDNA monitoring in patients with metastatic uveal melanoma undergoing isolated hepatic perfusion in combination with ipilimumab and nivolumab
In patients with UM liver metastases treated with combined hepatic perfusion and immune checkpoint inhibition, ctDNA may serve as a predictive biomarker and warrants further validation.
Authors
- Roger Olofsson Bagge (ORCID: https://orcid.org/0000-0001-5795-0355)
- Måns Kadefors (ORCID: https://orcid.org/0000-0002-7705-1485)
- Anders Ståhlberg (ORCID: https://orcid.org/0000-0003-4243-0191)
- Lars Ny (ORCID: https://orcid.org/0000-0003-3864-5958)
- Evelina Blomberg
- Anna Nelson (ORCID: https://orcid.org/0000-0001-7589-5564)
Institutions
- Sahlgrenska University Hospital (SE)
- Region Västra Götaland (SE)
- Institute for Biomedicine (IT)
- University of Gothenburg (SE)
Publication Details
- Journal
- Immuno-Oncology Technology
- Published
- 2025-10-26
- DOI
- https://doi.org/10.1016/j.iotech.2025.101079
- Primary Topic
- Ocular Oncology and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00